BMO Capital Upgrades Eli Lilly (LLY) to Outperform

BMO Capital upgraded Eli Lilly (NYSE: LLY) from Market Perform to Outperform with a price target of $100.00.

For an analyst ratings summary and ratings history on Eli Lilly click here. For more ratings news on Eli Lilly click here.

Shares of Eli Lilly closed at $79.55 yesterday.

You May Also Be Interested In

• BofA Securities Upgrades Humana (HUM) to Buy, 'The path to $45 EPS power by 2028'
• Truist Securities Upgrades Magnolia Oil & Gas Corp. (MGY) to Buy, 'we view the WildFire acquisition favorably'
• BofA Securities Upgrades Honeywell International (HON) to Neutral